Trials / Terminated
TerminatedNCT03026088
Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants
A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, open label, interventional, multi-center, phase 4 pilot study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bisoprolol | Participants received Bisoprolol orally, once daily at a dose of 1.25 milligram (mg) up to Weeks 3, and then it was up-titrated to 2.5 mg up to Week 6, 3.75 mg up to Week 10, 5 mg up to Week 14, 7.5 mg up to Week 18 and 10 mg up to Week 26. |
Timeline
- Start date
- 2017-03-21
- Primary completion
- 2018-12-26
- Completion
- 2018-12-26
- First posted
- 2017-01-20
- Last updated
- 2020-01-29
- Results posted
- 2020-01-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03026088. Inclusion in this directory is not an endorsement.